Keyphrases
Standard of Care
100%
Chemotherapy
100%
Phase II Trial
100%
Adjuvant Chemotherapy
100%
Locally Advanced Rectal Cancer
100%
Concurrent Chemoradiotherapy
100%
Transanal Total Mesorectal Excision (taTME)
100%
Short-course Radiotherapy
100%
RAPIDO
100%
Care Groups
88%
Disease-related
33%
Treatment Failure
33%
FOLFOX
33%
Hospital Policy
33%
CAPOX
33%
High Risk
22%
Twice Daily
22%
Infection Rate
22%
Pulmonary Embolism
22%
Distant Metastasis
22%
Treatment-related Mortality
22%
Oxaliplatin
22%
Experimental Therapeutics
22%
Between-day
22%
Intention-to-treat
22%
Nodal Stage
22%
Eastern Cooperative Oncology Group Performance Status (ECOG PS)
22%
Fluorouracil
22%
Capecitabine
22%
Clinical Tumor Stage
22%
Chemotherapy-free Interval
22%
Treatment Group
11%
Hazard Ratio
11%
Adverse Events
11%
Diarrhea
11%
Neurotoxicity
11%
Newly Diagnosed
11%
Clinical Trials Network
11%
Colorectal Cancer
11%
Induction Therapy
11%
Preoperative Therapy
11%
Cardiac Arrest
11%
Am(III)
11%
Serious Adverse Events
11%
Biopsy-proven
11%
Microvascular Invasion
11%
Preoperative Chemotherapy
11%
Rectal Adenocarcinoma
11%
Bolus
11%
Suicide
11%
First Occurrence
11%
New Standards
11%
Severe Depression
11%
Regional Failure
11%
Netherlands
11%
Sweden
11%
Management System
11%
Infectious Complications
11%
Leucovorin
11%
Block Design
11%
Locoregional Control
11%
Spain
11%
Trial Participants
11%
Locally Advanced
11%
Systemic Relapse
11%
Colorectal Tumor
11%
EudraCT
11%
Block Size
11%
Cumulative Probability
11%
Number of Events
11%
Dutch
11%
Slovenia
11%
New Primary
11%
Delayed Surgery
11%
Folinic Acid
11%
Mesorectal Fascia
11%
Pelvic MRI
11%
Lateral Lymph Node
11%
Neutropenic Sepsis
11%
Denmark-Norway
11%
Medicine and Dentistry
Care Group
100%
Chemoradiotherapy
100%
Adjuvant Chemotherapy
100%
Rectum Cancer
100%
Total Mesorectal Excision
100%
Radiation Therapy
100%
CAPOX
37%
Diseases
37%
Malignant Neoplasm
25%
Adverse Event
25%
Pulmonary Embolism
25%
Distant Metastasis
25%
Intention-to-Treat Analysis
25%
Oncology
25%
Experimental Therapy
25%
Oxaliplatin
25%
Fluorouracil
25%
Cancer Staging
25%
Folinic Acid
25%
Capecitabine
25%
Hazard Ratio
12%
Diarrhea
12%
Magnetic Resonance Imaging
12%
Clinical Research
12%
Pelvis
12%
Lymph Node
12%
Heart Arrest
12%
Sepsis
12%
Infectious Complication
12%
Preoperative Chemotherapy
12%
Rectum Carcinoma
12%
Fascia
12%
Biopsy Technique
12%
Colorectal Tumor
12%
Severe Depression
12%
Treatment Group
12%